Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Blauvelt Andrew and de Bruin-Weller Marjolein and Gooderham Melinda and Cather Jennifer C and Weisman Jamie and Pariser David and Simpson Eric L and Papp Kim A and Hong H Chih-Ho and Rubel Diana and Foley Peter and Prens Errol and Griffiths Christopher E M and Etoh Takafumi and Pinto Pedro Herranz and Pujol Ramon M and Szepietowski Jacek C and Ettler Karel and Kemény Lajos and Zhu Xiaoping and Akinlade Bolanle and Hultsch Thomas and Mastey Vera and Gadkari Abhijit and Eckert Laurent and Amin Nikhil and Graham Neil M H and Pirozzi Gianluca and Stahl Neil and Yancopoulos George D and Shumel Brad: Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
LANCET, 389 (10086). pp. 2287-2303. ISSN 0140-6736 (2017)

[thumbnail of 3230565_Blauvelt.pdf] Text
3230565_Blauvelt.pdf - Published Version
Closed access: Repository staff only

Download (561kB) | Request a copy
Item Type: Journal Article
Journal or Publication Title: LANCET
Date: 2017
Volume: 389
Number: 10086
Page Range: pp. 2287-2303
ISSN: 0140-6736
Publisher: The Lancet Publishing Group
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 3230565
DOI azonosító: https://doi.org/10.1016/S0140-6736(17)31191-1
Date Deposited: 2017. Oct. 19. 16:00
Last Modified: 2019. Oct. 22. 14:53
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/11568
Web of Science® Times Cited: 809 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year